Jennifer W Tidey1. 1. Center for Alcohol & Addiction Studies, Brown University, 121 South Main Street, Providence, RI 02912, USA. Jennifer_Tidey@brown.edu
Abstract
INTRODUCTION: Serious mental illness (SMI) is associated with high rates of tobacco and other drug dependence, poor treatment compliance, obesity and low levels of physical activity, which have severe medical and psychosocial consequences. Interventions that effectively reduce these health risk behaviors among people with SMI are urgently needed. METHODS: Published reports from studies evaluating incentive-based treatments for promoting tobacco and other drug abstinence, treatment attendance, medication use and increased physical activity are reviewed. RESULTS: Results of this review indicate the efficacy of incentive-based treatments for reducing tobacco and other drug use among people with SMI. Few studies have examined whether incentive-based treatments improve treatment attendance, medication use and physical activity levels in people with SMI; however, initial evidence is positive and indicates that further research in these areas is warranted. CONCLUSION: Given the medical and psychosocial costs of tobacco and other drug use, treatment non-compliance and physical inactivity, and the efficacy of incentive-based treatments for improving these behaviors, such interventions should be further developed and integrated into behavioral health treatment programs for people with SMI.
INTRODUCTION: Serious mental illness (SMI) is associated with high rates of tobacco and other drug dependence, poor treatment compliance, obesity and low levels of physical activity, which have severe medical and psychosocial consequences. Interventions that effectively reduce these health risk behaviors among people with SMI are urgently needed. METHODS: Published reports from studies evaluating incentive-based treatments for promoting tobacco and other drug abstinence, treatment attendance, medication use and increased physical activity are reviewed. RESULTS: Results of this review indicate the efficacy of incentive-based treatments for reducing tobacco and other drug use among people with SMI. Few studies have examined whether incentive-based treatments improve treatment attendance, medication use and physical activity levels in people with SMI; however, initial evidence is positive and indicates that further research in these areas is warranted. CONCLUSION: Given the medical and psychosocial costs of tobacco and other drug use, treatment non-compliance and physical inactivity, and the efficacy of incentive-based treatments for improving these behaviors, such interventions should be further developed and integrated into behavioral health treatment programs for people with SMI.
Authors: Miles McFall; Andrew J Saxon; Carol A Malte; Bruce Chow; Sara Bailey; Dewleen G Baker; Jean C Beckham; Kathy D Boardman; Timothy P Carmody; Anne M Joseph; Mark W Smith; Mei-Chiung Shih; Ying Lu; Mark Holodniy; Philip W Lavori Journal: JAMA Date: 2010-12-08 Impact factor: 56.272
Authors: Stefan Priebe; Alexandra Burton; Deborah Ashby; Richard Ashcroft; Tom Burns; Anthony David; Sandra Eldridge; Mike Firn; Martin Knapp; Rose McCabe Journal: BMC Psychiatry Date: 2009-09-28 Impact factor: 3.630
Authors: Haruka Minami; Hannah R Brinkman; Shadi Nahvi; Julia H Arnsten; Monica Rivera-Mindt; David W Wetter; Erika Litvin Bloom; Lawrence H Price; Carlos Vieira; Remington Donnelly; Lauren M McClain; Katherine A Kennedy; Erica D'Aquila; Micki Fine; Danielle E McCarthy; J Graham Thomas; Jacki Hecht; Richard A Brown Journal: Contemp Clin Trials Date: 2017-12-27 Impact factor: 2.226
Authors: Suchitra Krishnan-Sarin; Dana A Cavallo; Judith L Cooney; Ty S Schepis; Grace Kong; Thomas B Liss; Amanda K Liss; Thomas J McMahon; Charla Nich; Theresa Babuscio; Bruce J Rounsaville; Kathleen M Carroll Journal: Drug Alcohol Depend Date: 2013-03-22 Impact factor: 4.492
Authors: A-La Park; David McDaid; Prisca Weiser; Carolin Von Gottberg; Thomas Becker; Reinhold Kilian Journal: BMC Public Health Date: 2013-08-29 Impact factor: 3.295
Authors: Stefan Priebe; Ksenija Yeeles; Stephen Bremner; Christoph Lauber; Sandra Eldridge; Deborah Ashby; Anthony S David; Nicola O'Connell; Alexandra Forrest; Tom Burns Journal: BMJ Date: 2013-10-07